Structure Therapeutics (GPCR) Cash from Operations (2022 - 2026)
Quarterly Cash from Operations rose 129.17% to 15234000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 154736000.0 through Mar 2026, down 14.8% year-over-year, with the annual reading at 222199000.0 for FY2025, 90.51% down from the prior year.
Structure Therapeutics' Cash from Operations history spans 5 years, with the latest figure at 15234000.0 for Q1 2026.
- Cash from Operations came in at 15234000.0 for Q1 2026, up from 64416000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 15234000.0 in Q1 2026 to a low of 64416000.0 in Q4 2025.
- The 5-year median for Cash from Operations is 20557000.0 (2023), against an average of 26424058.82.
- Year-over-year, Cash from Operations tumbled 158.92% in 2025 and then skyrocketed 129.17% in 2026.
- Structure Therapeutics' Cash from Operations stood at 12026000.0 in 2022, then plummeted by 80.68% to 21729000.0 in 2023, then crashed by 67.83% to 36467000.0 in 2024, then plummeted by 76.64% to 64416000.0 in 2025, then surged by 123.65% to 15234000.0 in 2026.
- Per Business Quant, the three most recent readings for GPCR's Cash from Operations are 15234000.0 (Q1 2026), 64416000.0 (Q4 2025), and 50996000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.08 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 15.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.23 Mn |
| Mar 31, 2026 | 15.23 Mn |
| Dec 31, 2025 | -64.42 Mn |
| Dec 31, 2025 | -64.42 Mn |
| Sep 30, 2025 | -51.00 Mn |
| Sep 30, 2025 | -51.00 Mn |
| Jun 30, 2025 | -54.56 Mn |
| Jun 30, 2025 | -54.56 Mn |
| Mar 31, 2025 | -52.23 Mn |
| Mar 31, 2025 | -52.23 Mn |
| Dec 31, 2024 | -36.47 Mn |
| Dec 31, 2024 | -36.47 Mn |
| Sep 30, 2024 | -19.70 Mn |
| Sep 30, 2024 | -19.70 Mn |
| Jun 30, 2024 | -26.39 Mn |
| Jun 30, 2024 | -26.39 Mn |
| Mar 31, 2024 | -34.08 Mn |
| Mar 31, 2024 | -34.08 Mn |
| Dec 31, 2023 | -21.73 Mn |
| Dec 31, 2023 | -21.73 Mn |
| Sep 30, 2023 | -20.56 Mn |
| Sep 30, 2023 | -20.56 Mn |
| Jun 30, 2023 | -16.89 Mn |
| Jun 30, 2023 | -16.89 Mn |
| Mar 31, 2023 | -20.31 Mn |
| Mar 31, 2023 | -20.31 Mn |
| Dec 31, 2022 | -12.03 Mn |
| Dec 31, 2022 | -12.03 Mn |
| Sep 30, 2022 | -10.48 Mn |
| Sep 30, 2022 | -10.48 Mn |
| Jun 30, 2022 | -10.10 Mn |
| Jun 30, 2022 | -10.10 Mn |
| Mar 31, 2022 | -13.52 Mn |
| Mar 31, 2022 | -13.52 Mn |